Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
dc.contributor.author | Boykin, Christi | |
dc.contributor.author | Zhang, G. | |
dc.contributor.author | Chen, Yan-Hua | |
dc.contributor.author | Zhang, R-W | |
dc.contributor.author | Fan, X-E | |
dc.contributor.author | Yang, W-M | |
dc.contributor.author | Lu, Q. | |
dc.date.accessioned | 2016-05-24T18:40:32Z | |
dc.date.available | 2016-05-24T18:40:32Z | |
dc.date.issued | 2011-03 | |
dc.identifier.citation | British Journal of Cancer; 104:5 p. 781-789 | en_US |
dc.identifier.doi | 10.1038/bjc.2011.10 | |
dc.identifier.issn | 0007-0920 | |
dc.identifier.pmid | pmc3048206 | en_US |
dc.identifier.uri | http://hdl.handle.net/10342/5298 | |
dc.relation.uri | http://www.ncbi.nlm.nih.gov/pubmed/21304528 | en_US |
dc.title | Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation | en_US |
dc.type | Article | en_US |
ecu.journal.issue | 5 | en_US |
ecu.journal.name | British Journal of Cancer | en_US |
ecu.journal.pages | 781-789 | en_US |
ecu.journal.volume | 104 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- bjc201110a.PMC3048206.pdf
- Size:
- 757.01 KB
- Format:
- Adobe Portable Document Format